drugset / Trial / NCT02838992

Summary

To assess whether ATG Combined With Cyclophosphamide and cord blood infusion can accelerate hematopoietic reconstruction in severe aplastic anemia patients and improve clinical curative effect and safety

Timeline

Start
2017-02
Primary completion
2018-12
Completion
2019-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 50 mg/kg
Subject Influenza Virus Vaccine Vaccine Other
Background Cyclosporine Peptide 5 mg/kg
Background Thymoglobulin Protein / enzyme biologic 3 mg/kg Other

Indications